Versanis Bio Raises $70M in Series A Financing

01 Sep, 2021

Versanis Bio Raises $70M in Series A Financing
Photo by Mikel Parera on Unsplash

– Versanis Bio is an Oakland, Calif.-based company established to discover and develop first-in-class medicines that address medical conditions prevalent in older adults.
– The company closed a $70m Series A financing.
– The round was co-led by Atlas Venture and Medicxi with participation from Aditum Bio.
– The company intends to use the funds to advance a comprehensive phase 2 clinical program to evaluate the potential of bimagrumab to help obese patients lose fat and achieve an improved body composition.

Biotechnology Life Science Medical North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: